The study found that individuals with liver fibrosis exhibited significantly higher serum aldosterone levels, along with increased hepatic expression of NLRP3, a key inflammasome involved in fibrogenic signaling pathways [36]. The gene discussed is NLRP3; the disease is Hepatic fibrosis.